Cargando…

Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas

Molecular and clinical heterogeneity critically hinders better treatment outcome for glioblastomas (GBMs); integrative analysis of genomic and epigenomic data may provide useful information for improving personalized medicine. By applying training-validation approach, we identified a novel hypomethy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Anan, Etcheverry, Amandine, He, Yalong, Aubry, Marc, Barnholtz-Sloan, Jill, Zhang, Luhua, Mao, Xinggang, Chen, Weijun, Liu, Bolin, Zhang, Wei, Mosser, Jean, Zhang, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685695/ https://www.ncbi.nlm.nih.gov/pubmed/29163774 http://dx.doi.org/10.18632/oncotarget.19171

Ejemplares similares

A five‐CpG signature of microRNA methylation in non‐G‐CIMP glioblastoma
por: Kang, En‐Ming, et al.
Publicado: (2019)

Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
por: Yin, An-An, et al.
Publicado: (2019)

Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas
por: Yin, Anan, et al.
Publicado: (2021)

A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas
por: Li, Bowen, et al.
Publicado: (2022)

‘From the core to beyond the margin’: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2015)

Correction: From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2016)

The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line
por: Monnier, Annabelle, et al.
Publicado: (2018)

Immune genes are associated with human glioblastoma pathology and patient survival
por: Vauléon, Elodie, et al.
Publicado: (2012)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

DNA methylation in glioblastoma: impact on gene expression and clinical outcome
por: Etcheverry, Amandine, et al.
Publicado: (2010)

EMT is associated with an epigenetic signature of ECM remodeling genes
por: Peixoto, Paul, et al.
Publicado: (2019)

DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide
por: Etcheverry, Amandine, et al.
Publicado: (2014)

Integration of Raman spectra with transcriptome data in glioblastoma multiforme defines tumour subtypes and predicts patient outcome
por: Le Reste, Pierre‐Jean, et al.
Publicado: (2021)

Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma
por: Chen, Qi, et al.
Publicado: (2019)

Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme
por: Cheray, Mathilde, et al.
Publicado: (2020)

Integration of transcriptome and proteome profiles in glioblastoma: looking for the missing link
por: Lemée, Jean-Michel, et al.
Publicado: (2018)

The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma
por: Shi, Tingyu, et al.
Publicado: (2023)

EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas
por: Lachat, Camille, et al.
Publicado: (2020)

Treatment and surgical factors associated with longer-term glioblastoma survival: a National Cancer Database study
por: Malay, Sindhoosha, et al.
Publicado: (2020)

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
por: Gittleman, Haley, et al.
Publicado: (2019)

Identification of Variants in Primary and Recurrent Glioblastoma Using a Cancer-Specific Gene Panel and Whole Exome Sequencing
por: Virk, Selene M., et al.
Publicado: (2015)

Distinct chromatin signatures of DNA hypomethylation in aging and cancer
por: Pérez, Raúl F., et al.
Publicado: (2018)

Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence
por: Nickel, Gabrielle C., et al.
Publicado: (2012)

Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma
por: Furgason, John M., et al.
Publicado: (2015)

Knockdown of FRAT1 Expression by RNA Interference Inhibits Human Glioblastoma Cell Growth, Migration and Invasion
por: Guo, Geng, et al.
Publicado: (2013)

Frontiers of Oncology: Biobanking Resources for the 21(st )Century
por: Barnholtz-Sloan, Jill, et al.
Publicado: (2011)

Epidemiology of Brain and Other CNS Tumors
por: Ostrom, Quinn T., et al.
Publicado: (2021)

Simultaneous analysis of distinct Omics data sets with integration of biological knowledge: Multiple Factor Analysis approach
por: de Tayrac, Marie, et al.
Publicado: (2009)

Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation
por: Bobinet, Mathilde, et al.
Publicado: (2013)

Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database
por: Hodges, Tiffany R, et al.
Publicado: (2021)

Genome-Wide Methylation Analyses in Glioblastoma Multiforme
por: Lai, Rose K., et al.
Publicado: (2014)

Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
por: Gatson, Na Tosha N., et al.
Publicado: (2021)

Splitting random forest (SRF) for determining compact sets of genes that distinguish between cancer subtypes
por: Guan, Xiaowei, et al.
Publicado: (2012)

Integrated Analysis to Obtain Potential Prognostic Signature in Glioblastoma
por: Chen, Jia-Qi, et al.
Publicado: (2022)

Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
por: Guan, Xiaowei, et al.
Publicado: (2014)

Proteins inform survival-based differences in patients with glioblastoma
por: Stetson, L C, et al.
Publicado: (2020)

Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis
por: Sloan, Anthony R, et al.
Publicado: (2022)

COVD-17. TUMOR TREATING FIELDS FOR GLIOBLASTOMA THERAPY DURING THE COVID-19 PANDEMIC: EXPERT CONSENSUS ON USE AND EXPERIENCE
por: Tosha Gatson, Na, et al.
Publicado: (2020)

A comparison of relative survival and cause‐specific survival methods to measure net survival in cancer populations
por: Makkar, Nupur, et al.
Publicado: (2018)

BSCI-06. FREQUENCY OF BRAIN METASTASIS FROM BREAST AND LUNG CANCER IN THE UNITED STATES -- A POPULATION-BASED ASSESSMENT
por: Ostrom, Quinn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_88dglv2agl7fo69qfpdd7r7gmq